Today: 7 February 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Opendoor Stock Skyrockets 1300% Amid Meme Hype – Will the Rally Survive the Housing Slump?

Opendoor Stock Skyrockets 1300% Amid Meme Hype – Will the Rally Survive the Housing Slump?

The 1300% Rally and Meme Stock Frenzy Opendoor’s stock has experienced a jaw-dropping rally in 2025, transforming from a penny-stock into a retail trading sensation. After languishing below $1 per share through mid-year (and drawing a Nasdaq delisting warning), OPEN caught fire over the summer. A coalition of individual investors on Reddit and X (formerly Twitter) began touting Opendoor as the next big “meme stock,” similar to past hits like GameStop and AMCnasdaq.com. This social-media enthusiasm, combined with activist investor pressure, ignited a massive short squeeze and sent Opendoor shares rocketing up around 1,300% from their lowsnasdaq.com. The stock exploded
3 November 2025
···
Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Company Overview and Background Acrivon Therapeutics is a Boston-area biotech (NASDAQ: ACRV) founded in 2018, emerging with a mission to revolutionize cancer treatment through precision medicinestockanalysis.com. The company’s name “Acrivon” is derived from “accurate” or “precision,” reflecting its core approach: develop targeted oncology drugs hand-in-hand with diagnostics that pinpoint the patients who will respond. Acrivon’s proprietary platform, AP3 (Acrivon Predictive Precision Proteomics), lies at the heart of this strategy. Using proteomics and AI tools, AP3 measures the activity of myriad proteins and signaling pathways inside tumor cells in their native state, rather than just analyzing DNA mutationsglobenewswire.comglobenewswire.com. This allows Acrivon
3 November 2025
···
NIO Stock Skyrockets on Record Sales and Bold Moves – Can the Rally Last?

NIO Stock Skyrockets on Record Sales and Bold Moves – Can the Rally Last?

NIO Stock Performance: Latest Price and Short-Term Trend NIO’s stock has been on a notable upswing heading into November 2025. Shares closed at $7.25 on October 31, 2025 – a multi-month high – after jumping over 3% in a single day following the latest delivery reportstockinvest.us. This capped a strong week; NIO gained roughly 5.1% over the last week of October, even though it was still down a few percent over the full monthsimplywall.st. The late-October bounce reflects renewed investor enthusiasm around the company’s record sales figures and growth trajectory. It’s worth noting that NIO’s current price around $7+ represents
3 November 2025
····
TGE Stock’s Wild Ride: Why The Generation Essentials Group Is Making Headlines in Nov 2025

TGE Stock’s Wild Ride: Why The Generation Essentials Group Is Making Headlines in Nov 2025

Recent Stock Performance and Volatility (Late Oct – Early Nov 2025) TGE’s stock has experienced a rollercoaster in recent days, capturing investors’ attention. In the final week of October 2025, shares entered a freefall: between October 27 and October 31 the price plunged from highs near $1.89 to a low of $0.7777 intraday on Oct 31 Stockstotrade. The October 31 session was especially dramatic – TGE opened around $1.79 but collapsed over 50%, hitting that record low of $0.78 before closing at $1.01 Stockstotrade Stockstotrade. This marked a single-day drop of ~54%, capping a multi-day slide in which the stock
3 November 2025
·····
IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

Company Overview & Business Segments IDEXX Laboratories facility in Markham, Canada (one of the company’s global offices). IDEXX Laboratories, Inc. is a veterinary diagnostics and life sciences company that develops, manufactures, and sells products and services for animal health and water testing in over 175 countries Pestel Analysis Pestel Analysis. Founded in 1983 and headquartered in Maine, IDEXX has grown into the dominant player in pet healthcare diagnostics, as well as a significant provider in livestock/poultry and water microbiology testing. The company operates through three main business segments Wikipedia: Across these segments, IDEXX’s business model is built on selling durable
3 November 2025
·
Rani Therapeutics (RANI) Stock Skyrockets on Biotech Breakthrough: Inside the Surge and What’s Next

Rani Therapeutics (RANI) Stock Skyrockets on Biotech Breakthrough: Inside the Surge and What’s Next

RANI Stock Performance: From Penny Stock to Momentum Rocket Rani Therapeutics’ stock price has been on a tear in late 2025, turning heads in the biotech investing community. After languishing under $1 for most of the year, RANI exploded upward in October. It closed on Oct 31 at $2.20, up +51.7% in one dayfinviz.com on massive volume (~61 million shares vs ~15 million averagefinviz.com). In fact, over the past month RANI has climbed about 335%finviz.com. Just a few weeks ago in early October it was trading around 50–60 cents; by the first week of November it’s oscillating in the mid-$2s.
3 November 2025
····
MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

In short: MSP Recovery’s stock is trading at mere pennies after a spectacular rise-and-fall on Nov 3. The company is fighting for survival – juggling emergency financings, a looming Nasdaq delisting, and ongoing legal battles – all while attempting to transform its fortunes in the healthcare reimbursement industry. Company Overview: Business Model & Financials Business Model: MSP Recovery, Inc. is a 2014-founded Miami-based company that aims to recover reimbursements from Medicare, Medicaid, and other insurers on behalf of healthcare payerstipranks.com. Under the Medicare Secondary Payer (MSP) Act, if a private insurer should have paid a claim that Medicare/Medicaid covered, that
3 November 2025
·····
Dell Stock Skyrockets on AI Boom – Price Surge, Key News & 2025 Outlook

Dell Stock Skyrockets on AI Boom – Price Surge, Key News & 2025 Outlook

Dell Technologies (NASDAQ: DELL) stock is trading around $162 per share as of Nov. 3, 2025, near its 52-week high after a massive rally fueled by booming demand for AI serversmarketbeat.com. Shares have more than doubled in the past year (12-month low ~$66, high ~$168) and are up roughly 35% year-to-date, far outperforming the S&P 500 and most tech peersmarketbeat.com. In the last few days, major news – including a $5.8 billion AI hardware deal tied to Microsoft – has driven the stock higherreuters.com. Analysts remain bullish, citing Dell’s raised growth forecasts and strong positioning in enterprise AI, while company executives
3 November 2025
···
ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

Sources: Financial data from Yahoo Finance/Refinitivreuters.comreuters.com and company filings; GlobeNewswire press releaseglobenewswire.comglobenewswire.com; Reuters news reportreuters.com; Bernama (Malaysia) interview with CEObernama.combernama.com; Stock analysis sites and SEC filings for market cap and float detailsfinviz.comstocktitan.net. All statements and quotes are cited from these sources.
3 November 2025
···
Berkshire Hathaway’s Next Act: Trillion-Dollar BRK-B, Buffett’s Farewell & 2025 Forecasts

Berkshire Hathaway’s Next Act: Trillion-Dollar BRK-B, Buffett’s Farewell & 2025 Forecasts

Current Price & Recent Performance Berkshire Hathaway’s Class B stock (NYSE: BRK-B) trades around $477–$480 as of early November 2025stockinvest.us. The share price has eased off about 5% since mid-October, when it briefly crossed the $500 mark before pulling backstockinvest.us. Year-to-date, BRK-B is up roughly 8–9% in 2025, which means it has underperformed the S&P 500 (the S&P is up about 14–16% over the same period)tipranks.com. Berkshire’s stock had been at record highs earlier in the year, but it fell back after CEO Warren Buffett announced his retirement plans in May – since that news, the stock has lagged the broader
3 November 2025
···
Datavault AI (DVLT) Stock Skyrockets on AI Frenzy – Key Facts & Future Outlook

Datavault AI (DVLT) Stock Skyrockets on AI Frenzy – Key Facts & Future Outlook

Company Overview and Business Model Datavault AI Inc. is a young technology company at the intersection of artificial intelligence, blockchain, and data monetization. Its mission is to help organizations turn underutilized data into valuable assets. To do this, Datavault provides a cloud-based platform that combines high-performance computing (HPC) and Web 3.0 data management. In practice, the company’s software enables clients to securely manage their data (often on a blockchain ledger), “tokenize” data into digital assets, and create digital twins (virtual representations) of real-world datastocktitan.netstocktitan.net. This allows the data to be bought, sold, or licensed on exchanges, potentially unlocking new revenue
3 November 2025
·····
AMTD Digital (HKD) Skyrockets 180% on 1,085% Revenue Surge – Meme-Stock Mania 2.0 or Sustainable Comeback?

AMTD Digital (HKD) Skyrockets 180% on 1,085% Revenue Surge – Meme-Stock Mania 2.0 or Sustainable Comeback?

Company Overview & Background AMTD Digital Inc. is a subsidiary of the AMTD Group conglomerate and part of a broader family that includes parent AMTD IDEA Group (NYSE: AMTD). Founded in 2019 and initially based in Hong Kong, AMTD Digital positioned itself as a “one-stop” digital solutions platform. Its original business lines span digital financial services, the AMTD SpiderNet ecosystem (a connector network for Asian entrepreneurs), digital media, content & marketing, and digital investments in tech startupsreuters.comchartmill.com. The company capitalized on AMTD Group’s fintech roots – leveraging various financial licenses in Asia – while also investing in content and digital
3 November 2025
···
1 … 82 83 84 85 86 … 233

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop